RETA 10MG

Retatrutide is an investigational peptide designed to target three key metabolic hormone receptors: GLP-1, GIP, and glucagon (GCG). This triple-receptor approach is being studied for its potential effects on appetite regulation, glucose metabolism, energy expenditure, and body-weight reduction.

HOW IT WORKS

Retatrutide works through three complementary pathways:

GLP-1 Receptor: Helps regulate appetite, increase feelings of fullness, and slow gastric emptying.
GIP Receptor: Supports insulin secretion and plays a role in glucose and fat metabolism.
Glucagon Receptor: May increase energy expenditure and promote the body's utilization of stored energy.

KEY POTENTIAL BENEFITS

Weight Management: Clinical trials have demonstrated substantial reductions in body weight, with higher-dose groups in a Phase 2 obesity trial reaching an average reduction of approximately 24% at 48 weeks.

Blood Sugar & Metabolic Support: Retatrutide is being studied for its ability to improve glucose regulation, insulin sensitivity, and other metabolic markers.

Cardiometabolic Health: Research has shown improvements in several cardiometabolic risk factors, including blood pressure, triglycerides, cholesterol markers, and liver fat.

Joint & Mobility Support: Retatrutide is also being studied in people with obesity and knee osteoarthritis to determine whether weight reduction and metabolic improvements may contribute to improvements in pain and physical function.